Skip to content

Lyfstone Calprotectin for Synovial Fluid

by Calpro AS Norway EUDAMED

Ref LYFCLP001 EMDN W01010699

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-07090028590013 Basic UDI-DIDate29 Feb 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Lyfstone Calprotectin (CLP) Quantitative Test
Model / Reference
LYFCLP001
Primary DI / UDI-DI
07090028590013
Basic UDI-DI
B-07090028590013
EMDN Code
W01010699 Clin. chem. rt & poc - other
Device Class
Class IVD General
Market of Registration
Norway

Manufacturer details

EUDAMED SRN
NO-MF-000036194

Other devices from Calpro AS

See all devices from Calpro AS →

Properties & raw data

Show properties, registry sources and raw records
  • Reagent
  • Near-Patient Testing
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 8dc4e1e5-c509-4f18-b8b7-695c24ad64d0 61 fields · synced 24 Oct 2026